Rothschild & CO Asset Management Us Inc. Haemonetics Corp Transaction History

Rothschild & CO Asset Management Us Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $3.46 Million - $4.41 Million	-38,493 Closed	0 $0
Q2 2018 Aug 07, 2018	SELL	$71.53 - $95.75 $2.65 Million - $3.55 Million	-37,112 Reduced 49.09%	38,493 $3.45 Million
Q1 2018 May 08, 2018	SELL	$60.72 - $74.41 $493,592 - $604,878	-8,129 Reduced 9.71%	75,605 $5.53 Million
Q4 2017 Feb 12, 2018	SELL	$44.96 - $58.99 $244,762 - $321,141	-5,444 Reduced 6.1%	83,734 $4.86 Million
Q3 2017 Nov 08, 2017	BUY	$40.38 - $44.87 $3.6 Million - $4 Million	89,178	89,178 $4 Million

334

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.58B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.